tiprankstipranks
Trending News
More News >
MSP Recovery (MSPR)
NASDAQ:MSPR
US Market
Advertisement

MSP Recovery (MSPR) AI Stock Analysis

Compare
398 Followers

Top Page

MSPR

MSP Recovery

(NASDAQ:MSPR)

Rating:39Underperform
Price Target:
$2.00
▼(-10.71% Downside)
MSP Recovery's overall stock score is heavily impacted by its poor financial performance, characterized by significant losses and high leverage. Technical analysis suggests bearish momentum, and valuation metrics are unattractive due to negative earnings. Recent corporate events add further uncertainty, with a mix of negative and positive developments.

MSP Recovery (MSPR) vs. SPDR S&P 500 ETF (SPY)

MSP Recovery Business Overview & Revenue Model

Company DescriptionMSP Recovery, Inc. operates as a healthcare recoveries and data analytics company in the United States and Puerto Rico. The company offers claims recovery services, including services to related parties or third parties to assist entities with pursuit of claims recovery rights. It also provides Chase to pay service to assist its healthcare provider clients to identify in the first instance the proper primary insurer at the point of care and thereby avoid making a wrongful payment; and LifeWallet, a platform designed to locate and organize users' medical records. MSP Recovery, Inc. was founded in 2014 and is headquartered in Coral Gables, Florida.
How the Company Makes MoneyMSP Recovery generates revenue through a contingency-based model, where it receives a percentage of the funds recovered on behalf of its clients, which primarily include healthcare providers and payers. Key revenue streams include recovery fees from successful claims, analytics services that provide insights into recovery opportunities, and partnerships with healthcare organizations that enable access to larger datasets for more efficient recovery processes. Additionally, MSPR may engage in settlements with various healthcare programs, further contributing to its earnings.

MSP Recovery Earnings Call Summary

Earnings Call Date:Aug 07, 2025
(Q1-2024)
|
% Change Since: |
Next Earnings Date:Nov 12, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted LifeWallet's successful settlements and increased claims recovery income, demonstrating progress in its core business model. However, the company also reported a significant operating loss, primarily due to noncash items. Overall, while there are substantial achievements, the financial results reflect ongoing challenges.
Q1-2024 Updates
Positive Updates
Successful Settlements with Insurers
LifeWallet achieved two comprehensive settlements with multiple property and casualty insurers, resolving claims and establishing a process for future claims. The settlements include provisions for data sharing and a 5-year agreement for binding mediation of Medicare claim liens.
Increased Claims Recovery Income
The company generated claims recovery income of $6 million in Q1 2024, up from $3.5 million in Q1 2023, indicating progress in its recovery strategies.
Expansion of Data Collaboration
LifeWallet entered into a tri-party data collaboration agreement with Palantir Technologies and 28 affiliated settling counterparties to enhance its ability to reconcile Medicare liabilities.
Liquidity and Financial Flexibility
LifeWallet extended its obligations with Virage, Nomura, and Yorkville to 2025, and secured a working capital credit facility with an additional $14 million borrowing capacity.
Negative Updates
Significant Operating Loss
LifeWallet reported an operating loss of $130 million for Q1 2024, with 93% attributed to noncash items such as claims amortization expense.
Intangible Asset Decrease
Total assets decreased by $124 million from December 31, 2023, primarily due to the amortization of intangible assets.
Company Guidance
During the LifeWallet First Quarter 2024 earnings call, the company provided guidance highlighting significant achievements and financial metrics. LifeWallet reached two comprehensive settlements with property and casualty insurers, which included agreements to provide 10 years of historical data and to collaboratively resolve future Medicare claims. These settlements resulted in claims recovery income of $6 million for Q1 2024, an increase from the $3.5 million reported in Q1 2023. The company reported a total operating loss of $130 million, primarily driven by non-cash items, with an adjusted operating loss of $8.7 million after excluding claims amortization expenses. LifeWallet's total assets were valued at $3 billion, with liabilities amounting to $1.8 billion. The company has extended various obligations to 2025 and secured additional liquidity through a working capital credit facility and a Yorkville standby equity purchase agreement, ensuring its ability to meet cash obligations over the next year.

MSP Recovery Financial Statement Overview

Summary
MSP Recovery faces significant financial difficulties, characterized by persistent losses, high leverage, and negative cash flows. The company's financial health is under strain, with limited signs of improvement in profitability or liquidity.
Income Statement
15
Very Negative
The income statement reveals significant challenges, with negative net profit margins and declining EBIT and EBITDA margins over time. Despite a slight revenue growth in the TTM period, the company struggles with profitability, as evidenced by substantial net losses and negative EBIT margins.
Balance Sheet
10
Very Negative
The balance sheet indicates high financial leverage with a negative stockholders' equity and a concerning debt-to-equity ratio. The negative return on equity further highlights the company's inability to generate profits from its equity base, posing substantial financial risk.
Cash Flow
20
Very Negative
Cash flow analysis shows negative operating and free cash flows, with a slight improvement in free cash flow to net income ratio. However, the overall negative cash flow position and declining free cash flow growth rate underscore liquidity challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue13.28M18.25M7.71M23.42M14.63M13.89M
Gross Profit4.63M8.64M5.56M21.37M14.09M13.71M
EBITDA-584.24M-652.46M-69.22M-522.49M-5.52M-3.13M
Net Income-581.26M-360.50M-56.35M-7.42M-33.09M-24.25M
Balance Sheet
Total Assets1.67B1.92B3.16B3.42B104.01M17.84M
Cash, Cash Equivalents and Short-Term Investments3.99M12.33M11.63M3.66M1.66M11.88M
Total Debt861.21M794.66M679.22M324.25M213.61M48.09M
Total Liabilities2.28B2.05B1.74B1.23B255.41M133.69M
Stockholders Equity-207.16M100.58M272.39M109.69M-155.76M-120.18M
Cash Flow
Free Cash Flow-23.16M-16.65M-41.77M-83.62M1.62M-344.00K
Operating Cash Flow-20.61M-16.12M-40.02M-80.64M2.25M-14.00K
Investing Cash Flow-111.38M-2.73M7.56M-5.68M-2.01M986.00K
Financing Cash Flow20.03M19.54M29.02M99.73M-10.46M9.61M

MSP Recovery Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.24
Price Trends
50DMA
5.79
Negative
100DMA
8.85
Negative
200DMA
11.24
Negative
Market Momentum
MACD
-0.95
Negative
RSI
23.39
Positive
STOCH
26.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MSPR, the sentiment is Negative. The current price of 2.24 is below the 20-day moving average (MA) of 3.66, below the 50-day MA of 5.79, and below the 200-day MA of 11.24, indicating a bearish trend. The MACD of -0.95 indicates Negative momentum. The RSI at 23.39 is Positive, neither overbought nor oversold. The STOCH value of 26.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MSPR.

MSP Recovery Risk Analysis

MSP Recovery disclosed 95 risk factors in its most recent earnings report. MSP Recovery reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

MSP Recovery Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.91B-0.36-41.71%2.23%23.45%-1.86%
39
Underperform
$14.43M-2151.29%76.98%-52.89%
$2.59M-66.29%
$39.64M
38
Underperform
$11.00M-3190.66%-280.85%
22
Underperform
$219.68K-467.31%17369.91%69.56%
$4.16M-88.35%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MSPR
MSP Recovery
2.24
-26.65
-92.25%
WORX
SCWorx
0.31
-0.77
-71.30%
ONMD
OneMedNet
0.86
-0.06
-6.52%
FOXO
FOXO Technologies
0.01
-2.97
-99.66%
VSEE
VSee Health
0.67
-0.75
-52.82%
ACON
Aclarion, Inc.
7.30
-1,652.46
-99.56%

MSP Recovery Corporate Events

Stock Split
MSP Recovery Implements Reverse Stock Split
Neutral
Sep 2, 2025

On September 1, 2025, MSP Recovery, Inc. implemented a reverse stock split, consolidating every seven shares of its Class A and Class V Common Stock into one share, without altering the par value. This move, approved by a majority of stockholders on August 18, 2025, aimed to increase the market price per share to comply with Nasdaq rules. The reverse split reduced the number of Class A shares from approximately 7.2 million to 1 million and Up-C Units from 3.3 million to 0.5 million, affecting all stockholders uniformly without altering their percentage ownership.

Legal ProceedingsBusiness Operations and Strategy
MSP Recovery Subsidiary Liable for $12.7M in Damages
Negative
Aug 26, 2025

On August 20, 2025, a jury in the Menendez Litigation found MSP Recovery, LLC, a subsidiary of MSP Recovery, Inc., liable for breach of an alleged oral contract, awarding plaintiffs $12.7 million in damages. Although the jury exonerated the parent company and its CEO, John H. Ruiz, from fraud and misrepresentation claims, the verdict has introduced uncertainty regarding the company’s financial condition and may impact its ability to raise capital or continue operations. The company plans to challenge the verdict through post-trial motions and potential appeals.

Shareholder MeetingsStock Split
MSP Recovery Approves Reverse Stock Split Amendment
Neutral
Aug 18, 2025

On August 18, 2025, MSP Recovery, Inc. held a Special Meeting of its Stockholders, where approximately 74.74% of stockholders were present. During the meeting, stockholders approved an amendment to the company’s Charter for a reverse stock split at a ratio between 1-for-2 and 1-for-7, and the issuance of Class A Common Stock to Virage Recovery Master LP, in compliance with Nasdaq Listing Rule 5635(d).

Private Placements and FinancingShareholder MeetingsBusiness Operations and Strategy
MSP Recovery Holds 2025 Annual Meeting with Key Decisions
Neutral
Aug 8, 2025

On November 14, 2023, MSP Recovery, Inc. entered into a Standby Equity Purchase Agreement with Yorkville, allowing the company to sell up to $250 million of its common stock shares. The agreement includes issuing convertible promissory notes, with Yorkville advancing $16.5 million in total. The company held its 2025 Annual Meeting on August 8, 2025, where stockholders re-elected three directors and ratified Deloitte as the independent auditor for the fiscal year. These developments may impact MSP Recovery’s financial strategy and governance structure.

Private Placements and FinancingBusiness Operations and Strategy
MSP Recovery Adjusts Floor Price in Yorkville SEPA
Neutral
Aug 5, 2025

On August 5, 2025, MSP Recovery and Yorkville agreed to lower the Floor Price under the Yorkville SEPA from $1.00 to $0.50. This adjustment may impact the company’s financial agreements and market positioning by potentially altering the terms of their capital arrangements.

Private Placements and Financing
MSP Recovery Enters Equity Purchase Agreement with Yorkville
Neutral
Jul 16, 2025

On November 14, 2023, MSP Recovery, Inc. entered into a Standby Equity Purchase Agreement with Yorkville, allowing the company to sell up to $250 million of its common stock to Yorkville under certain conditions. The agreement also includes advances in the form of convertible promissory notes, with Yorkville having the option to convert these notes into common stock, impacting the company’s financial operations and potentially its market positioning.

Legal ProceedingsBusiness Operations and Strategy
MSP Recovery Wins Key Legal Battle Against GEICO
Positive
Jul 15, 2025

On July 15, 2025, MSP Recovery announced a significant legal victory as the Maryland Supreme Court ruled in favor of the company’s claim assignments, allowing its federal class action lawsuit against GEICO to proceed. This decision, which rejects GEICO’s arguments against MSP’s assignment model, is expected to have broader implications for related litigation across various jurisdictions, reinforcing MSP Recovery’s strategy and mission to hold primary insurers accountable for reimbursement obligations.

Private Placements and FinancingBusiness Operations and Strategy
MSP Recovery Amends Promissory Note with Nomura
Neutral
Jun 27, 2025

On June 26, 2025, MSP Recovery, Inc. amended its promissory note with Nomura Securities International, increasing the principal to approximately $33.6 million and waiving Nomura’s entitlement to $3 million from the Yorkville SEPA. Additionally, the company has been engaging with Yorkville under a Standby Equity Purchase Agreement, allowing it to sell up to $250 million in shares. This includes issuing convertible promissory notes, with the latest being a $0.8 million note on June 26, 2025, which Yorkville can convert into shares, impacting the company’s financial strategy and shareholder dynamics.

Private Placements and FinancingBusiness Operations and Strategy
MSP Recovery Lowers Floor Price in Yorkville SEPA
Negative
Jun 5, 2025

On June 5, 2025, MSP Recovery and Yorkville agreed to lower the Floor Price under the Yorkville SEPA from $3.75 to $1.00. Hazel and Virage expressed willingness to negotiate additional working-capital funding to support the company’s ongoing claim servicing, which could impact MSP Recovery’s financial operations and stakeholder interests.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 05, 2025